Consolidated Statement of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities
Net income (loss)	$ (1,012,203)	$ (8,815,744)
Loss from discontinued operations	72,321	748,262
Adjustments to reconcile net loss to net cash used in operating activities:
Gain from disposal of discontinued operations	(2,674,069)
Depreciation and amortization	352,027	829,481
Impairment loss	319,958	2,745,563
Stock based compensation, including amortization of deferred equity compensation	303,979	439,763
Gain from expiration of liability classified equity instruments	(92,641)
Amortization of debt discount	427,808	55,282
Stock-based financing cost		100,000
Loss on extinguishment of debt	145,212
Gain from realization of contingent sale consideration receivable	(1,090,857)
Change in fair value of contingent acquisition consideration	(11,094)	(779,999)
Changes in operating assets and liabilities:
Accounts receivable	28,916	36,510
Inventory	59,611	(44,631)
Contract assets	264,626	(269,736)
Prepaid expenses and deposits	(31,299)	51,532
Right of use lease assets	403,287	351,718
Accounts payable and accrued expenses	(780,239)	701,605
Lease liability	(402,292)	(350,566)
Contract liabilities	(303,073)	527,010
Net cash used in continuing operating activities	(4,020,022)	(3,673,950)
Net cash used in discontinued operating activities	(124,846)	(689,070)
Net cash used in operating activities	(4,144,868)	(4,363,020)
Cash Flows from Investing Activities
Acquisition, net of cash acquired		(313,802)
Payment of contingent acquisition consideration		(207,384)
Proceeds from sale of discontinued operations	3,507,612
Acquisition of property and equipment	(1,500)	(23,564)
Net cash provided by (used in) continuing investing activities	3,506,112	(544,750)
Net cash used in discontinued investing activities
Net cash provided by (used in) investing activities	3,506,112	(544,750)
Cash Flows from Financing Activities
Proceeds from sale of common stock	850,000	956,787
Proceeds from related party notes payable	1,198,500	260,000
Proceeds from third party notes payable	1,283,249	683,300
Repayment of related party notes payable	(1,411,004)	(28,000)
Repayment of third party notes payable	(1,096,658)	(194,072)
Net cash provided by continuing financing activities	824,087	1,678,015
Net cash provided by discontinued financing activities
Net cash provided by financing activities	824,087	1,678,015
Net increase (decrease) in cash	185,331	(3,229,755)
Cash, beginning of period	61,891	3,291,646
Cash, end of period	247,222	61,891
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	21,041	5,923
Cash paid during the period for income tax
Schedule of non-cash investing and financing activities:
Common stock issuable issued during period	108,928	305,069
Net carrying value of equity liabilities (assets) written off	64,647	428,859
Recognition of operating lease: right of use asset and lease liability	798,918	284,905
Proceeds from sale of common stock under Standby Equity Purchase Agreement applied to note payable balance	18,765	279,415
Debt discount and original issue discount allocated to proceeds of notes payable	367,919	153,631
Fair value of warrants allocated to proceeds of notes payable	187,013	35,281
Fair value of beneficial conversion feature allocated to proceeds of notes payable	33,000
Fair value of warrants issued to extend debt	50,025
Warrant liability incurred in connection with collection of contingent sale consideration receivable	10,820
Fair value of shares issued to pay vendor accounts payable balance	48,881
Fair value of shares issued as purchase price consideration		$ 103,804